Patents by Inventor Bryndis BIRNIR

Bryndis BIRNIR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GABA A receptor agonists for treatment of disorders influenced by dysfunction BETA cells
    Patent number: 12161695
    Abstract: The present invention relates to methods for treatment or prevention of disorders caused influenced by dysfunction of ? cells by administering to said patient a compound selected from the group consisting of GABAA receptor agonists. The invention further relates to in vitro methods for finding potentially useful pharmaceutical compounds.
    Type: Grant
    Filed: February 21, 2019
    Date of Patent: December 10, 2024
    Assignee: DIAMYD MEDICAL AB
    Inventors: Bryndis Birnir, Ulf Hannelius, Anton Lindqvist
  • NEW USE AND METHODS OF MODULATING IMMUNE RESPONSES
    Publication number: 20210113586
    Abstract: The present invention relates to methods for identifying patients a subject at risk of developing an autoimmune or inflammatory disorder, as well as methods of prevention of development of an autoimmune or inflammatory disorder, comprising administering GABA, or a GABA receptor agonist, to a subject so identified. The invention furthermore relates to methods for assessing a subject's susceptibility to treatment with gamma-aminobutyric acid (GABA) or a GABA receptor agonist, as well as biomarkers to be used in the assessment of the response of a GABA treatment.
    Type: Application
    Filed: February 25, 2019
    Publication date: April 22, 2021
    Inventors: Bryndis BIRNIR, Ulf HANNELIUS, Anton LINDQVIST
  • GABA A RECEPTOR AGONISTS FOR TREATMENT OF DISORDERS INFLUENCED BY DYSFUNCTION BETA CELLS
    Publication number: 20200384086
    Abstract: The present invention relates to methods for treatment or prevention of disorders caused influenced by dysfunction of ? cells by administering to said patient a compound selected from the group consisting of GABAA receptor agonists. The invention further relates to in vitro methods for finding potentially useful pharmaceutical compounds.
    Type: Application
    Filed: February 21, 2019
    Publication date: December 10, 2020
    Inventors: Bryndis BIRNIR, Ulf HANNELIUS, Anton LINDQVIST